サインイン

Alboukadel Kassambara

IGH,
CNRS,
IGH, CNRS

BIOGRAPHY

Alboukadel Kassambara has not added Biography.

If you are Alboukadel Kassambara and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells.

British journal of cancer Apr, 2018 | Pubmed ID: 29500406

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs.

Clinical epigenetics Oct, 2018 | Pubmed ID: 30285865

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway.

Cancer letters Feb, 2019 | Pubmed ID: 30419344

INSTITUTIONS

Univ Montpellier

JOVE ARTICLES

Michel Jourdan¹,

Hugues de Boussac¹,

Elena Viziteu¹,

Alboukadel Kassambara¹,

Jérôme Moreaux^1,2,3

¹IGH, CNRS, Univ Montpellier,

²Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, CHU Montpellier,

³UFR de Médecine, Univ Montpellier

Immunology and Infection

個人情報保護方針

利用規約

一般データ保護規則

お問い合わせ

図書館への推薦

JoVE ニュースレター

研究

教育

著者

図書館員

JoVEについて